Invivyd, Inc. — Director's Dealing 2022

Feb 2, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adagio Therapeutics, Inc. (ADGI)
CIK: 0001832038
Period of Report: 2022-01-30

Reporting Person: Andersen Jill (Chief Legal Officer, Secretary)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-01-30	Stock Option (Right to Buy)	$6.78	A	575000	Acquired	2032-01-29	Common Stock (575000)	Direct

Footnotes

F1: This option vests in equal monthly installments over a four-year period measured from one month following January 30, 2022, subject to the Reporting Person's continuous service as of the applicable vesting date.